tm logo
X4 PHARMACEUTICALS
Live/Registered
REGISTERED

on 12 Oct 2021

Last Applicant/ Owned by

955 Massachusetts Avenue, 4th floor

Cambridge

MA

02139

Serial Number

88516679 filed on 16th Jul 2019

Registration Number

6521316 registered on 12th Oct 2021

in the Principal Register

Correspondent Address

Glenn A. Gundersen

Glenn A. Gundersen

2929 ARCH STREET, CIRA CENTRE

PHILADELPHIA, PA 19104-2808

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

X4 PHARMACEUTICALS

Research and development in the pharmaceutical field; scientific research; scientific investigations for medical purposes Pharmaceutical preparations for the treatment of cancers, rare diseases, primary immune disorders and other diseases

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development in the pharmaceutical field; scientific research; scientific investigations for medical purposes


First Use Date in General

11th Jun 2019

First Use Date in Commerce

11th Jun 2019

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cancers, rare diseases, primary immune disorders and other diseases


First Use Date in General

23rd Jun 2020

First Use Date in Commerce

23rd Jun 2020

Mark Details


Serial Number

No 88516679

Mark Type

No Service Mark

Attorney Docket Number

No 166289-001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Oct 2021REGISTERED-PRINCIPAL REGISTER
08th Sep 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07th Sep 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
20th Aug 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Aug 2021SOU EXTENSION 4 GRANTED
19th Aug 2021STATEMENT OF USE PROCESSING COMPLETE
11th Aug 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
11th Aug 2021USE AMENDMENT FILED
10th Aug 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
10th Aug 2021ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST